cgmp fda No Further a Mystery
No. 21 CFR 211.113(a) requires proper published processes for being proven and adopted throughout manufacturing to circumvent objectionable microorganisms in drug solutions not needed to be sterile. On top of that, the second paragraph of USP Basic Chapter Antimicrobial Usefulness Testing reads: Antimicrobial preservatives should not be ap